Table 1.
Clinical data of patients with spinal ASPS and literature review
| No. | Age, sex | Preoperative status | Treatment | Follow-up | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Loca | OML | Pri/LR/meta (PS) | AT | F-S pre | Blood loss (ml) | Surgery time (min) | Type | Appro | Comp | F-S post | Follow-up month | LR/meta | Last status | ||
| 1 | 28, M | L5 | Lung pubis | Meta (right leg) | Targ/radio | C | 3200 | 110 | Piecemeal | Post | D | 34 | AWD | ||
| 2 | 30, M | S3-5 | Pri | D | 1000 | 230 | Piecemeal | Post | E | 15 | NED | ||||
| 3 | 22, F | S2 | Lung | LR | Chemo | D | NA | 230 | Piecemeal | Post | E | 13 | NED | ||
| 4 | 44, F | L2-4 | Lung, scull | Meta (sacrum) | Chemo/radio | D | 1000 | 155 | Piecemeal | Post | D | 3 | Recu | ||
| L2/3 | Lung, scull | LR | Chemo/radio | C | 1000 | 130 | Piecemeal | Post | D | 21 | AWD | ||||
| 5 | 16, F | S1-5 | Pri | D-C | 5000 | 505 | Piecemeal | Post | Wound disunion | D | 3 | Meta | |||
| C7T1 | Lung | Meta | Chemo | C | 2000 | 170 | Piecemeal | Ant | C | 1 | Recu | ||||
| C6-7 | Lung | LR | Chemo | A | 1600 | 300 | Piecemeal | Post | B | 4 | DOD | ||||
| Zhu et al. [10] | 23, M | T12 | Pri | NA | NA | NA | Piecemeal | Post | NA | NA | NA | NA | NA | ||
| Zadnik et al. [9] | 28, F | S1-3 | Pri | C | NA | NA | En-bloc | NA | NA | D | 26 | Recu | DOD | ||
| Lizzati et al. [11] | 36, F | T3-6 | NA | Meta (NA) | Chemo/radio | D | 2500 | 880 | En-bloc | Thoracotomy post | Meningocele | E | 18 | NED | |
Loca location, OML other metastatic lesions, Pri primary, LR local recurrence, Meta metastasis, PS primary site, AT adjuvant therapy, F-S Pre preoperative Frankel score, Appro approach, Comp complication, F-S post postoperative Frankel score, M male, F female, NA not available, Targ targeted therapy, Chemo chemotherapy, Radio radiotherapy, DOD died of disease, NED no evidence of disease, AWD alive with disease